TOLERANT B-LYMPHOCYTES ACQUIRE RESISTANCE TO FAS-MEDIATED APOPTOSIS AFTER TREATMENT WITH INTERLEUKIN-4 BUT NOT AFTER TREATMENT WITH SPECIFIC ANTIGEN UNLESS A SURFACE-IMMUNOGLOBULIN THRESHOLD IS EXCEEDED
Lc. Foote et al., TOLERANT B-LYMPHOCYTES ACQUIRE RESISTANCE TO FAS-MEDIATED APOPTOSIS AFTER TREATMENT WITH INTERLEUKIN-4 BUT NOT AFTER TREATMENT WITH SPECIFIC ANTIGEN UNLESS A SURFACE-IMMUNOGLOBULIN THRESHOLD IS EXCEEDED, The Journal of experimental medicine, 187(6), 1998, pp. 847-853
Susceptibility to Fas-mediated apoptosis in nontolerant B cells is reg
ulated in a receptor-specific fashion. To explore the regulation of Fa
s killing in tolerant, autoreactive B cells, mice doubly transgenic fo
r hen egg lysozyme (HEL)-specific B cell receptors and soluble HEL wer
e examined. Engagement of CD40 led to enhanced Fas expression and acqu
isition of sensitivity to Fas-mediated apoptosis in tolerant B cells,
similar to that observed in nontolerant, receptor transgenic B cells.
Engagement of surface immunoglobulin by specific (HEL) antigen failed
to induce Fas resistance in tolerant B cells, in contrast to its effec
t on nontolerant B cells; however, cross-linking of biotinylated HEL w
ith streptavidin induced similar levels of Fas resistance in tolerant
and nontolerant B cells, which approximated the degree of Fas resistan
ce produced by anti-Ig. Unlike surface Ig (sig) engagement, physiologi
cal engagement of IL-4 receptors produced similar levels of Fas resist
ance in tolerant and nontolerant B cells. Thus, tolerant B cells diffe
r from nontolerant B cells in the diminished capacity of surface immun
oglobulin engagement to produce Fas resistance; however, tolerant B ce
lls can be induced to become resistant to Fas-mediated apoptosis by IL
-4 or by higher order cross-linking of sIg receptors.